We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Vaxon Biotech Successfully Completes its Phase I/II Trial of Vx-001 Cancer Vaccine

News   May 21, 2010

 
Vaxon Biotech Successfully Completes its Phase I/II Trial of Vx-001 Cancer Vaccine
 
 
 

RELATED ARTICLES

Drug Reduces Menstrual Bleeding for Women with Gynecologic Tumors

News

A new oral drug significantly reduced menstrual bleeding for women with the most common gynecologic tumors in the United States - benign tumors that disproportionately affect African-Americans, an international clinical trial found.

READ MORE

Biopatch Delivers Exact Drug Doses Directly into Cells

News

Minimally invasive patch developed by Purdue researchers delivers exact doses directly into cells, lessens pain and toxicity.

READ MORE


 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE